title: Reply to Arends and Harkisoen.
authors.affiliation: Center for Infectious Medicine, Karolinska Institutet.
authors.forename: Anna
authors.initials: A
authors.lastname: Linnér
authors.affiliation: Department of Infectious Diseases, Uppsala University.
authors.forename: Jan
authors.initials: J
authors.lastname: Sjölin
authors.affiliation: Public Health Agency of Sweden.
authors.forename: Jessica
authors.initials: J
authors.lastname: Darenberg
authors.affiliation: Department of Infectious Diseases, Uppsala University Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm Karolinska University Hospital, Solna, Sweden.
authors.forename: Birgitta
authors.initials: B
authors.lastname: Henriques-Normark
authors.affiliation: Center for Infectious Medicine, Karolinska Institutet.
authors.forename: Anna
authors.initials: A
authors.lastname: Norrby-Teglund
mesh_terms: D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D012772:Shock, Septic / Q000628:therapy*; D013290:Streptococcal Infections / Q000628:therapy*
chemical_list: D016756:Immunoglobulins, Intravenous